⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30019538 | 0.80 | — | — | |
| SCHEMBL19403598 | 0.80 | — | — | |
| SCHEMBL12668195 | 0.80 | — | — | |
| SCHEMBL2735703 | 0.76 | ALDH1A1 (0.36) | — | |
| SCHEMBL24637738 | 0.74 | — | — | |
| SCHEMBL21182213 | 0.74 | — | — | |
| SCHEMBL26819400 | 0.74 | — | — | |
| SCHEMBL23257393 | 0.74 | — | — | |
| SCHEMBL18752341 | 0.74 | ALDH1A1 (0.34) | — | |
| SCHEMBL171075 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12264168-B2 | Ruthenium compound, thin-film forming raw material, and method of producing thin film | ADEKA CORPORATION (JP) | 2025-04-01 | — | — | US | disclosed |
| WO-2023225534-A1 | AROMATIC BORON-CONTAINING COMPOUNDS AND RELATED INSULIN ANALOGS | PROTOMER TECHNOLOGIES INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| EP-4231804-A2 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2023-08-23 | — | — | EP | disclosed |
| WO-2022261473-A1 | PROTEASE INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2022-12-15 | — | — | WO | disclosed |
| US-20220372056-A1 | RUTHENIUM COMPOUND, THIN-FILM FORMING RAW MATERIAL, AND METHOD OF PRODUCING THIN FILM | ADEKA CORPORATION (JP) | 2022-11-24 | — | — | US | disclosed |
| US-11370773-B1 | Inhibiting human integrin (alpha-4) (beta-7) | MORPHIC THERAPEUTIC, INC. (US) | 2022-06-28 | — | — | US | disclosed |
| EP-3192511-B1 | PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2021-07-14 | — | — | EP | disclosed |
| WO-2016079711-A1 | SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2016-05-26 | — | — | WO | disclosed |
| WO-2014078637-A1 | NOVEL HETEROCYCLIC DERIVATIVES AS MODULATORS OF KINASE ACTIVITY | MERCK PATENT GMBH (DE) | 2014-05-22 | — | — | WO | disclosed |